DK2202307T3 - Fremgangsmåde til fremstiling af et antistof - Google Patents

Fremgangsmåde til fremstiling af et antistof

Info

Publication number
DK2202307T3
DK2202307T3 DK08838661.0T DK08838661T DK2202307T3 DK 2202307 T3 DK2202307 T3 DK 2202307T3 DK 08838661 T DK08838661 T DK 08838661T DK 2202307 T3 DK2202307 T3 DK 2202307T3
Authority
DK
Denmark
Prior art keywords
antibody
producing
Prior art date
Application number
DK08838661.0T
Other languages
English (en)
Other versions
DK2202307T4 (da
Inventor
Yoshiki Yamada
Tatsuya Kiyasu
Kazuyuki Tabata
Akihiro Kuzumaki
Mai Yamashiro
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2202307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DK2202307T3 publication Critical patent/DK2202307T3/da
Application granted granted Critical
Publication of DK2202307T4 publication Critical patent/DK2202307T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK08838661.0T 2007-10-15 2008-10-14 Fremgangsmåde til fremstiling af et antistof DK2202307T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007267384 2007-10-15
JP2008103308 2008-04-11
PCT/JP2008/068588 WO2009051108A1 (ja) 2007-10-15 2008-10-14 抗体の製造方法

Publications (2)

Publication Number Publication Date
DK2202307T3 true DK2202307T3 (da) 2014-09-15
DK2202307T4 DK2202307T4 (da) 2021-10-04

Family

ID=40567372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08838661.0T DK2202307T4 (da) 2007-10-15 2008-10-14 Fremgangsmåde til fremstiling af et antistof

Country Status (17)

Country Link
US (3) US9683027B2 (da)
EP (1) EP2202307B2 (da)
JP (4) JP4976502B2 (da)
KR (1) KR101558009B1 (da)
CN (3) CN101802192A (da)
AU (1) AU2008312937B2 (da)
BR (1) BRPI0818674B1 (da)
CA (1) CA2701338C (da)
DK (1) DK2202307T4 (da)
ES (1) ES2499391T5 (da)
IL (2) IL205051A (da)
MX (1) MX2010004007A (da)
PL (1) PL2202307T5 (da)
SG (1) SG185302A1 (da)
SI (1) SI2202307T2 (da)
TW (1) TWI463010B (da)
WO (1) WO2009051108A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4976502B2 (ja) * 2007-10-15 2012-07-18 中外製薬株式会社 抗体の製造方法
WO2011051231A1 (en) 2009-10-26 2011-05-05 F. Hoffmann-La Roche Ag Method for the production of a glycosylated immunoglobulin
JP6001456B2 (ja) * 2010-12-28 2016-10-05 中外製薬株式会社 動物細胞の培養方法
EP2968544A4 (en) * 2013-03-15 2016-10-12 Hoffmann La Roche CELL CULTURE MEDIA AND METHOD FOR PRODUCING ANTIBODY
CN105378480B (zh) 2013-07-04 2018-06-12 豪夫迈·罗氏有限公司 检测血清样品中抗药物抗体的干扰抑制性免疫测定
WO2018002036A1 (en) 2016-06-28 2018-01-04 Zaklady Farmaceutyczne Polpharma Sa Recombinant production of monoclonal antibodies
EP3541413A2 (en) 2016-11-21 2019-09-25 Polpharma Biologics S.A. Aqueous pharmaceutical formulations
WO2025134341A1 (ja) * 2023-12-22 2025-06-26 中外製薬株式会社 抗体の製造方法
WO2025141786A1 (ja) * 2023-12-27 2025-07-03 中外製薬株式会社 抗体の製造方法
WO2025232879A1 (en) 2024-05-10 2025-11-13 Cytocares (Shanghai) Inc. Anti-lilrb2 monospecific and bispecific antibody constructs and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPS6459878A (en) 1987-08-31 1989-03-07 Matsushita Electric Industrial Co Ltd Semiconductor laser protective circuit
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0585287B1 (en) 1990-07-10 1999-10-13 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
EP0548267A4 (en) † 1990-09-04 1994-11-23 Salk Inst Biotech Ind Production of insulin-like growth factor-1 in methylotrophic yeast cells
EP0628639B1 (en) † 1991-04-25 1999-06-23 Chugai Seiyaku Kabushiki Kaisha Reconstituted human antibody against human interleukin 6 receptor
AU665025B2 (en) 1991-09-23 1995-12-14 Cambridge Antibody Technology Limited Production of chimeric antibodies - a combinatorial approach
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
CA2124967C (en) 1991-12-17 2008-04-08 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
DE69333823T2 (de) 1992-03-24 2006-05-04 Cambridge Antibody Technology Ltd., Melbourn Verfahren zur herstellung von gliedern von spezifischen bindungspaaren
NZ255101A (en) 1992-07-24 1997-08-22 Cell Genesys Inc A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
CA2161351C (en) 1993-04-26 2010-12-21 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
EP0731842A1 (en) 1993-12-03 1996-09-18 Medical Research Council Recombinant binding proteins and peptides
US5531053A (en) 1994-06-14 1996-07-02 Hamm; Hans Spring fastener for holding insulation against an inner surface of cavity walling
CA2194907A1 (en) 1994-07-13 1996-02-01 Kouji Matsushima Reshaped human antibody against human interleukin-8
US5561053A (en) 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP0823941A4 (en) 1995-04-28 2001-09-19 Abgenix Inc HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
EP0985033A4 (en) * 1997-04-04 2005-07-13 Biosite Inc POLYVALENT AND POLYCLONAL LIBRARIES
JP4213224B2 (ja) 1997-05-02 2009-01-21 ジェネンテック，インコーポレーテッド ヘテロマルチマー及び共通成分を有する多重特異性抗体の製造方法
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US20030003097A1 (en) † 2001-04-02 2003-01-02 Idec Pharmaceutical Corporation Recombinant antibodies coexpressed with GnTIII
US6605176B2 (en) * 2001-07-13 2003-08-12 Taiwan Semiconductor Manufacturing Co., Ltd. Aperture for linear control of vacuum chamber pressure
EP2022799A2 (en) 2001-11-16 2009-02-11 Biogen Idec Inc. Polycistronic expression of antibodies
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
ATE490787T1 (de) 2003-07-15 2010-12-15 Chugai Pharmaceutical Co Ltd Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm- produktion
AU2005222963B2 (en) * 2004-03-15 2009-10-29 Biogen Idec Ma Inc. Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
CN1842540B (zh) 2004-07-09 2012-07-04 中外制药株式会社 抗-磷脂酰肌醇蛋白聚糖3抗体
GB0425534D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
EP2468768A3 (en) * 2005-07-21 2012-10-31 Abbott Laboratories Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
JP4976502B2 (ja) * 2007-10-15 2012-07-18 中外製薬株式会社 抗体の製造方法

Also Published As

Publication number Publication date
BRPI0818674B1 (pt) 2023-01-17
CN101802192A (zh) 2010-08-11
WO2009051108A1 (ja) 2009-04-23
JP6506786B2 (ja) 2019-04-24
CA2701338C (en) 2018-09-18
IL240122B (en) 2019-02-28
ES2499391T3 (es) 2014-09-29
US20210300996A1 (en) 2021-09-30
JP6092304B2 (ja) 2017-03-08
CN103540632A (zh) 2014-01-29
JP4976502B2 (ja) 2012-07-18
IL205051A0 (en) 2010-11-30
ES2499391T5 (es) 2021-12-22
KR101558009B1 (ko) 2015-10-19
KR20100074184A (ko) 2010-07-01
US11136375B2 (en) 2021-10-05
SI2202307T1 (sl) 2014-11-28
EP2202307A1 (en) 2010-06-30
CA2701338A1 (en) 2009-04-23
PL2202307T3 (pl) 2015-02-27
JP2015198663A (ja) 2015-11-12
MX2010004007A (es) 2010-06-15
AU2008312937B2 (en) 2015-01-22
BRPI0818674A2 (pt) 2014-10-14
US12145978B2 (en) 2024-11-19
US20170275351A1 (en) 2017-09-28
TW200934867A (en) 2009-08-16
US20100291627A1 (en) 2010-11-18
DK2202307T4 (da) 2021-10-04
JP2017079794A (ja) 2017-05-18
SI2202307T2 (sl) 2021-11-30
IL205051A (en) 2015-09-24
EP2202307B2 (en) 2021-07-14
EP2202307B1 (en) 2014-08-20
AU2008312937A1 (en) 2009-04-23
EP2202307A4 (en) 2012-01-25
JP2012143246A (ja) 2012-08-02
JP5788830B2 (ja) 2015-10-07
CN106244651A (zh) 2016-12-21
JPWO2009051108A1 (ja) 2011-03-03
TWI463010B (zh) 2014-12-01
US9683027B2 (en) 2017-06-20
IL240122A0 (en) 2015-09-24
PL2202307T5 (pl) 2021-10-04
SG185302A1 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
DK2054711T3 (da) Fremgangsmåde til fremstilling af mikroarrays
DK2044002T3 (da) Fremgangsmåde til fremstilling af 3-substituerede 2-amino-5-halobenzamider
DK3730045T3 (da) Fremgangsmåde til indføring af en analytsensor
DK2202307T4 (da) Fremgangsmåde til fremstiling af et antistof
DK2350128T3 (da) Fremgangsmåder til fremstilling af antistoffer fra plasmaceller
DK2451839T3 (da) Fremgangsmåde til produktion af variable domæner
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
PL2155838T3 (pl) Sposób wytwarzania węglowodorów rozgałęzionych
DK2126801T3 (da) Fremgangsmåde til udvælgelse af information
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
DK1844662T3 (da) Metode til belægning af objekter
DK2531526T3 (da) Fremgangsmåde til opnåelse af antistoffer
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK2029567T3 (da) Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
PL2155839T3 (pl) Sposób wytwarzania węglowodorów rozgałęzionych
DK3106875T3 (da) Fremgangsmåde til detektering af cancer
FI20075505L (fi) Menetelmä silmälasien valmistamiseksi
DK2061746T3 (da) Fremgangsmåde til fremstilling af diestere
DK2076330T3 (da) Fremgangsmåde til fremstilling af katalysatorer
DK2367783T3 (da) Fremgangsmåde til fremstilling af et isocyanat
DK2019118T3 (da) Fremgangsmåde til syntetisering af thymosiner
DK2160225T3 (da) Fremgangsmåde til fremstilling af krystaller
DK1976960T3 (da) Fremgangsmåde til fremstilling af biodiesel